It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Polycomb group proteins (PcG), polycomb repressive complexes 1 and 2 (PRC1 and 2), repress lineage inappropriate genes during development to maintain proper cellular identities. It has been recognized that PRC1 localizes at the replication fork, however, the precise functions of PRC1 during DNA replication are elusive. Here, we reveal that a variant PRC1 containing PCGF1 (PCGF1-PRC1) prevents overloading of activators and chromatin remodeling factors on nascent DNA and thereby mediates proper deposition of nucleosomes and correct downstream chromatin configurations in hematopoietic stem and progenitor cells (HSPCs). This function of PCGF1-PRC1 in turn facilitates PRC2-mediated repression of target genes such as Hmga2 and restricts premature myeloid differentiation. PCGF1-PRC1, therefore, maintains the differentiation potential of HSPCs by linking proper nucleosome configuration at the replication fork with PcG-mediated gene silencing to ensure life-long hematopoiesis.
Here the authors show that a Polycomb Repressive Complex 1 (PRC1) containing PCGF1 prevents excessive loading of transcriptional activators and chromatin remodelers on nascent DNA, allowing proper deposition of nucleosomes immediately after the passage of the DNA replication fork to optimize downstream chromatin configurations in hematopoietic stem and progenitor cells (HSPCs).
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details







1 RIKEN Center for Integrative Medical Sciences (RIKEN-IMS), Laboratory for Immune Regeneration, Yokohama, Japan (GRID:grid.509459.4) (ISNI:0000 0004 0472 0267); RIKEN Center for Integrative Medical Sciences, Laboratory for Developmental Genetics, Yokohama, Japan (GRID:grid.509459.4) (ISNI:0000 0004 0472 0267); Graduate School of Medical and Pharmaceutical Sciences, Chiba University, Department of Cellular and Molecular Medicine, Chiba, Japan (GRID:grid.136304.3) (ISNI:0000 0004 0370 1101)
2 RIKEN Center for Integrative Medical Sciences, Laboratory for Developmental Genetics, Yokohama, Japan (GRID:grid.509459.4) (ISNI:0000 0004 0472 0267)
3 The Institute of Medical Science, University of Tokyo, Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, Tokyo, Japan (GRID:grid.26999.3d) (ISNI:0000 0001 2151 536X)
4 Laboratory for Microbiome Sciences, RIKEN-IMS, Yokohama, Japan (GRID:grid.7597.c) (ISNI:0000000094465255)
5 Laboratory for Integrative Genomics, RIKEN-IMS, Yokohama, Japan (GRID:grid.7597.c) (ISNI:0000000094465255)
6 RIKEN Center for Integrative Medical Sciences, Laboratory for Developmental Genetics, Yokohama, Japan (GRID:grid.509459.4) (ISNI:0000 0004 0472 0267); Wakayama Medical University, Laboratory Animal Center, Wakayama, Japan (GRID:grid.412857.d) (ISNI:0000 0004 1763 1087)
7 RIKEN Center for Integrative Medical Sciences (RIKEN-IMS), Laboratory for Immune Regeneration, Yokohama, Japan (GRID:grid.509459.4) (ISNI:0000 0004 0472 0267); RIKEN Center for Integrative Medical Sciences, Laboratory for Developmental Genetics, Yokohama, Japan (GRID:grid.509459.4) (ISNI:0000 0004 0472 0267)
8 Tokyo University of Science, Noda, Division of Immunology and Allergy, Research Institute for Biomedical Sciences, Chiba, Japan (GRID:grid.143643.7) (ISNI:0000 0001 0660 6861)
9 Kazusa DNA Research Institute, Chromosome Engineering Team, Department of Technology Development, Kisarazu, Japan (GRID:grid.410858.0) (ISNI:0000 0000 9824 2470)
10 Institute for Protein Research, Laboratory of Computational Biology, Osaka, Japan (GRID:grid.136593.b) (ISNI:0000 0004 0373 3971); Laboratory for Transcriptome Technology, RIKEN-IMS, Yokohama, Japan (GRID:grid.7597.c) (ISNI:0000000094465255)
11 Laboratory for Applied Regulatory Genomics Network Analysis, RIKEN-IMS, Yokohama, Japan (GRID:grid.7597.c) (ISNI:0000000094465255)
12 University of Oxford, Department of Biochemistry, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948)
13 RIKEN Center for Integrative Medical Sciences, Laboratory for Developmental Genetics, Yokohama, Japan (GRID:grid.509459.4) (ISNI:0000 0004 0472 0267); Graduate School of Medical and Pharmaceutical Sciences, Chiba University, Department of Cellular and Molecular Medicine, Chiba, Japan (GRID:grid.136304.3) (ISNI:0000 0004 0370 1101)
14 RIKEN Center for Integrative Medical Sciences (RIKEN-IMS), Laboratory for Immune Regeneration, Yokohama, Japan (GRID:grid.509459.4) (ISNI:0000 0004 0472 0267); Tokyo University of Science, Noda, Division of Immunology and Allergy, Research Institute for Biomedical Sciences, Chiba, Japan (GRID:grid.143643.7) (ISNI:0000 0001 0660 6861)